Roberto Fernández-Acosta is a postdoctoral researcher and assistant professor at the Department of Pharmacy, University of Havana (UH). He received a bachelor’s degree in Radiochemistry (UH, 2015) and a master’s degree in Pharmacology (UH, 2017). He obtained his PhD in Pharmaceutical Sciences (UH, 2023) thanks to a collaboration project with the Molecular Signaling and Cell Death Unit (VIB/UGent-IRC) headed by Prof. Dr. Peter Vandenabeele. He is interested in cell death studies applied to cancer therapy.
Roberto Fernández-Acosta is a postdoctoral researcher and assistant professor at the Department of Pharmacy, University of Havana (UH). He received a bachelor’s degree in Radiochemistry (UH, 2015) and a master’s degree in Pharmacology (UH, 2017). He obtained his PhD in Pharmaceutical Sciences (UH, 2023) thanks to a collaboration project with the Molecular Signaling and Cell Death Unit (VIB/UGent-IRC) headed by Prof. Dr. Peter Vandenabeele. He is interested in cell death studies applied to cancer therapy.